| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Benefit-Risk Assessment of Erlotinib in Non-Small-Cell Lung Cancer and Pancreatic Cancer
|
Mountzios, Giannis
|
|
2011
|
|
3 |
p. 175-186
|
artikel
|
| 2 |
A Computerized Adverse Drug Event Alerting System Using Clinical Rules
|
Rommers, Mirjam K.
|
|
2011
|
|
3 |
p. 233-242
|
artikel
|
| 3 |
Addressing Limitations in Observational Studies of the Association Between Glucose-Lowering Medications and All-Cause Mortality: A Review
|
Patorno, Elisabetta
|
|
2015
|
|
3 |
p. 295-310
|
artikel
|
| 4 |
Adverse Effects of Intravenous Immunoglobulin Therapy
|
Nydegger, Urs E.
|
|
|
|
3 |
p. 171-185
|
artikel
|
| 5 |
A Framework for Assessing the Economic Value of Pharmacovigilance in Low- and Middle-Income Countries
|
Babigumira, Joseph B.
|
|
2014
|
|
3 |
p. 127-134
|
artikel
|
| 6 |
A Method for the Minimization of Competition Bias in Signal Detection from Spontaneous Reporting Databases
|
Arnaud, Mickael
|
|
2015
|
|
3 |
p. 251-260
|
artikel
|
| 7 |
An Algorithm for Comprehensive Medication Management in Nursing Homes: Results of the AMBER Project
|
Erzkamp, Susanne
|
|
|
|
3 |
p. 313-325
|
artikel
|
| 8 |
An Overview of Regression Models for Adverse Events Analysis
|
Coz, Elsa
|
|
|
|
3 |
p. 205-216
|
artikel
|
| 9 |
Antidepressant Discontinuation Syndromes
|
Haddad, Peter M.
|
|
|
|
3 |
p. 183-197
|
artikel
|
| 10 |
A Review on Application of DNA Barcoding Technology for Rapid Molecular Diagnostics of Adulterants in Herbal Medicine
|
Senapati, Alok
|
|
|
|
3 |
p. 193-213
|
artikel
|
| 11 |
A Risk-Benefit Analysis of Methadone Maintenance Treatment
|
Bell, James
|
|
2000
|
|
3 |
p. 179-190
|
artikel
|
| 12 |
A Risk-Benefit Assessment of Levofloxacin in Respiratory, Skin and Skin Structure, and Urinary Tract Infections
|
Martin, Steven J.
|
|
|
|
3 |
p. 199-222
|
artikel
|
| 13 |
Assessing the Safety of Drugs in Pregnancy
|
Irl, Cornelia
|
|
2000
|
|
3 |
p. 169-177
|
artikel
|
| 14 |
A Systematic Review and Meta-Analysis Considering the Risk for Congenital Heart Defects of Antidepressant Classes and Individual Antidepressants
|
De Vries, Courtney
|
|
|
|
3 |
p. 291-312
|
artikel
|
| 15 |
Authors’ Reply to Mona Kargar and Colleagues’ Comment on “Adverse Drug Reaction-Related Hospitalizations in Elderly Australians: A Prospective Cross-Sectional Study in Two Tasmanian Hospitals”
|
Parameswaran Nair, Nibu
|
|
2017
|
|
3 |
p. 323-324
|
artikel
|
| 16 |
Benefit–Risk Assessment of Diacerein in the Treatment of Osteoarthritis
|
Panova, Elena
|
|
2015
|
|
3 |
p. 245-252
|
artikel
|
| 17 |
Benefits and Risks of Long-Term Asthma Management in Children: Where Are We Heading?
|
Raissy, Hengameh H.
|
|
2016
|
|
3 |
p. 201-210
|
artikel
|
| 18 |
Bisphosphonates and Atrial Fibrillation
|
Loke, Yoon Kong
|
|
2009
|
|
3 |
p. 219-228
|
artikel
|
| 19 |
Brand-Specific Enhanced Safety Surveillance of GSK’s Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain for the 2018/2019 Season
|
Dos Santos, Gael
|
|
|
|
3 |
p. 265-279
|
artikel
|
| 20 |
Cancer Event Rate and Mortality with Thienopyridines: A Systematic Review and Meta-Analysis
|
Kotronias, Rafail Angelos
|
|
2016
|
|
3 |
p. 229-240
|
artikel
|
| 21 |
Cannabinoid-Related Acute Pancreatitis: An Update from International Literature and Individual Case Safety Reports
|
Azam, Camille
|
|
|
|
3 |
p. 215-235
|
artikel
|
| 22 |
Can SGLT2 Inhibitors Cause Acute Renal Failure? Plausible Role for Altered Glomerular Hemodynamics and Medullary Hypoxia
|
Szalat, Auryan
|
|
2017
|
|
3 |
p. 239-252
|
artikel
|
| 23 |
Carbapenems in Serious Infections
|
Norrby, S. Ragnar
|
|
2000
|
|
3 |
p. 191-194
|
artikel
|
| 24 |
Cardiac Safety of the Trastuzumab Biosimilar ABP 980 in Women with HER2-Positive Early Breast Cancer in the Randomized, Double-Blind, Active-Controlled LILAC Study
|
Kolberg, Hans-Christian
|
|
|
|
3 |
p. 233-242
|
artikel
|
| 25 |
Changes in Erythropoiesis Stimulating Agent Use Under a Risk Evaluation and Mitigation Strategy (REMS) Program
|
Sarpatwari, Ameet
|
|
|
|
3 |
p. 327-335
|
artikel
|
| 26 |
Changing Prescribing in the Light of Tolerability Concerns
|
de Vries, Corrine S.
|
|
|
|
3 |
p. 153-160
|
artikel
|
| 27 |
Clinicians’ Reports in Electronic Health Records Versus Patients’ Concerns in Social Media: A Pilot Study of Adverse Drug Reactions of Aspirin and Atorvastatin
|
Topaz, Maxim
|
|
2015
|
|
3 |
p. 241-250
|
artikel
|
| 28 |
Colchicine Drug Interaction Errors and Misunderstandings: Recommendations for Improved Evidence-Based Management
|
Hansten, Philip D.
|
|
|
|
3 |
p. 223-242
|
artikel
|
| 29 |
Comment on: “Adverse Drug Reaction-Related Hospitalizations in Elderly Australians: A Prospective Cross-Sectional Study in Two Tasmanian Hospitals”
|
Kargar, Mona
|
|
2017
|
|
3 |
p. 321-322
|
artikel
|
| 30 |
Comparative Safety Analysis of Opioid Agonist Treatment in Pregnant Women with Opioid Use Disorder: A Population-Based Study
|
Wang, Shuang
|
|
|
|
3 |
p. 257-271
|
artikel
|
| 31 |
Comparative Safety and Tolerability of Anti-VEGF Therapy in Age-Related Macular Degeneration
|
Modi, Yasha S.
|
|
2015
|
|
3 |
p. 279-293
|
artikel
|
| 32 |
Computational Approaches for Pharmacovigilance Signal Detection: Toward Integrated and Semantically-Enriched Frameworks
|
Koutkias, Vassilis G.
|
|
2015
|
|
3 |
p. 219-232
|
artikel
|
| 33 |
Contribution of Causality Assessment for an Automated Detection of Safety Signals: An Example Using the French Pharmacovigilance Database
|
Berbain, Thomas
|
|
|
|
3 |
p. 243-253
|
artikel
|
| 34 |
Correcting QT for Heart Rate When Both are Affected by a Drug
|
Ferber, Georg
|
|
2018
|
|
3 |
p. 335-337
|
artikel
|
| 35 |
Correction: Compliance with Prescribing and Dispensing Conditions for Valproate and Related Substances in Girls and Women of Childbearing Potential: A Survey of Community Pharmacists in France
|
Fauvelle, Khristina
|
|
|
|
3 |
p. 323
|
artikel
|
| 36 |
Correction to: DNA Barcoding and Pharmacovigilance of Herbal Medicines
|
de Boer, Hugo J.
|
|
|
|
3 |
p. 397
|
artikel
|
| 37 |
Correction to: Implications of Individual QT/RR Profiles—Part 1: Inaccuracies and Problems of Population-Specific QT/Heart Rate Corrections
|
Malik, Marek
|
|
2019
|
|
3 |
p. 473
|
artikel
|
| 38 |
Correction to: Implications of Individual QT/RR Profiles—Part 2: Zero QTc/RR Correlations Do Not Prove QTc Correction Accuracy in Studies of QTc Changes
|
Malik, Marek
|
|
2019
|
|
3 |
p. 475
|
artikel
|
| 39 |
Correction to: Individual Case Safety Report Replication: An Analysis of Case Reporting Transmission Networks
|
van Stekelenborg, John
|
|
|
|
3 |
p. 325
|
artikel
|
| 40 |
Correction to: The Moroccan Experience of Implementing a University Curriculum for the Pharmacovigilance of Herbal Medicines (Phytovigilance)
|
Skalli, Souad
|
|
|
|
3 |
p. 287-288
|
artikel
|
| 41 |
Dealing with Global Safety Issues
|
Stockbridge, Norman
|
|
2013
|
|
3 |
p. 167-182
|
artikel
|
| 42 |
Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System
|
Fusaroli, Michele
|
|
|
|
3 |
p. 283-295
|
artikel
|
| 43 |
Developing a Crowdsourcing Approach and Tool for Pharmacovigilance Education Material Delivery
|
Bate, Andrew
|
|
2017
|
|
3 |
p. 191-199
|
artikel
|
| 44 |
Developing Crowdsourced Training Data Sets for Pharmacovigilance Intelligent Automation
|
Gartland, Alex
|
|
|
|
3 |
p. 373-382
|
artikel
|
| 45 |
Diabetes Mellitus in Pregnancy
|
Albert Reece, E.
|
|
|
|
3 |
p. 209-220
|
artikel
|
| 46 |
Distinguishing Hazards and Harms, Adverse Drug Effects and Adverse Drug Reactions
|
Aronson, Jeffrey K.
|
|
2013
|
|
3 |
p. 147-153
|
artikel
|
| 47 |
Drug–Drug Interaction of the Sodium Glucose Co-Transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data
|
Alkabbani, Wajd
|
|
|
|
3 |
p. 287-295
|
artikel
|
| 48 |
Drug-Induced Aseptic Meningitis
|
Jolles, Stephen
|
|
2000
|
|
3 |
p. 215-226
|
artikel
|
| 49 |
Drug-Induced Hypophosphatemia: Current Insights
|
Megapanou, Efstathia
|
|
|
|
3 |
p. 197-210
|
artikel
|
| 50 |
Drug-Induced Liver Injury: Highlights of the Recent Literature
|
Real, Mark
|
|
2018
|
|
3 |
p. 365-387
|
artikel
|
| 51 |
Drug-Induced Oesophageal Disorders
|
Jaspersen, Daniel
|
|
2000
|
|
3 |
p. 237-249
|
artikel
|
| 52 |
Drug Safety Information Through the Internet
|
Polimeni, Giovanni
|
|
2009
|
|
3 |
p. 245-253
|
artikel
|
| 53 |
Drug Safety Meta-Analysis: Promises and Pitfalls
|
Stoto, Michael A.
|
|
2015
|
|
3 |
p. 233-243
|
artikel
|
| 54 |
Drug Utilization of Intrinsa® (Testosterone Patch) in England
|
Osborne, Vicki
|
|
2010
|
|
3 |
p. 213-221
|
artikel
|
| 55 |
Effect of Medications for Gastric Acid-Related Symptoms on Total Motile Sperm Count and Concentration: A Case–Control Study in Men of Subfertile Couples from the Netherlands
|
Huijgen, Nicole A.
|
|
2016
|
|
3 |
p. 241-248
|
artikel
|
| 56 |
Effect of Previous Anticoagulant Treatment on Risk of COVID-19
|
Zapata-Cachafeiro, Maruxa
|
|
|
|
3 |
p. 273-281
|
artikel
|
| 57 |
Effect of Tyrosine Kinase Inhibitors on Wound Healing and Tissue Repair: Implications for Surgery in Cancer Patients
|
Shah, Devron R.
|
|
2014
|
|
3 |
p. 135-149
|
artikel
|
| 58 |
Electrocardiographic Data Quality in Thorough QT/QTc Studies
|
Johannesen, Lars
|
|
2014
|
|
3 |
p. 191-197
|
artikel
|
| 59 |
Enhancing Transparency in Defining Studied Drugs: The Open-Source Living DiAna Dictionary for Standardizing Drug Names in the FAERS
|
Fusaroli, Michele
|
|
|
|
3 |
p. 271-284
|
artikel
|
| 60 |
Erratum to: Measuring the Severity of Prescribing Errors: A Systematic Review
|
Garfield, Sara
|
|
2014
|
|
3 |
p. 199
|
artikel
|
| 61 |
Evaluation of an Automated Surveillance System Using Trigger Alerts to Prevent Adverse Drug Events in the Intensive Care Unit and General Ward
|
DiPoto, John P.
|
|
2015
|
|
3 |
p. 311-317
|
artikel
|
| 62 |
Evaluation of ‘Definite’ Anaphylaxis Drug Allergy Alert Overrides in Inpatient and Outpatient Settings
|
Wong, Adrian
|
|
2017
|
|
3 |
p. 297-302
|
artikel
|
| 63 |
Evaluation of Drug-Induced Serious Hepatotoxicity (eDISH)
|
Watkins, Paul B.
|
|
2011
|
|
3 |
p. 243-252
|
artikel
|
| 64 |
Evaluation of Opioid Overdose Reports in Patients Treated with Extended-Release Naltrexone: Postmarketing Data from 2006 to 2018
|
Jain, Priya
|
|
|
|
3 |
p. 351-359
|
artikel
|
| 65 |
Evaluation of the Reported Rates of Severe Hypersensitivity Reactions Associated with Ferric Carboxymaltose and Iron (III) Isomaltoside 1000 in Europe Based on Data from EudraVigilance and VigiBase™ between 2014 and 2017
|
Ehlken, Birgit
|
|
2019
|
|
3 |
p. 463-471
|
artikel
|
| 66 |
Expectations for Feedback in Adverse Drug Reporting by Healthcare Professionals in the Netherlands
|
Oosterhuis, Ingrid
|
|
2012
|
|
3 |
p. 221-232
|
artikel
|
| 67 |
Exposure to Oral Fluoroquinolones and the Risk of Retinal Detachment: Retrospective Analyses of Two Large Healthcare Databases
|
Fife, Daniel
|
|
2014
|
|
3 |
p. 171-182
|
artikel
|
| 68 |
Fatal Toxicity Indices for Medicine-Related Deaths in New Zealand, 2008–2013
|
Fountain, John S.
|
|
|
|
3 |
p. 223-232
|
artikel
|
| 69 |
‘First, Do No Harm’: Factors that Influence Pharmacists Making Decisions about Over-the-Counter Medication
|
Hanna, Lezley-Anne
|
|
2010
|
|
3 |
p. 245-255
|
artikel
|
| 70 |
Follow-Up on the Use of Machine Learning in Clinical Quality Assurance: Can We Detect Adverse Event Under-Reporting in Oncology Trials?
|
Ménard, Timothé
|
|
|
|
3 |
p. 295-296
|
artikel
|
| 71 |
Hepatotoxicity Associated with the Use of Anti-TNF-α Agents
|
French, Joshua B.
|
|
|
|
3 |
p. 199-208
|
artikel
|
| 72 |
Hepatotoxicity Associated with the Use of Anti-TNF-α Agents
|
French, Joshua B.
|
|
2015
|
|
3 |
p. 199-208
|
artikel
|
| 73 |
High-Dimensional Propensity Score-Adjusted Case-Crossover for Discovering Adverse Drug Reactions from Computerized Administrative Healthcare Databases
|
Volatier, Etienne
|
|
|
|
3 |
p. 275-285
|
artikel
|
| 74 |
How are the Costs of Drug-Related Morbidity Measured?
|
Gyllensten, Hanna
|
|
2012
|
|
3 |
p. 207-219
|
artikel
|
| 75 |
How Do Patients Contribute to Signal Detection?
|
Hazell, Lorna
|
|
2013
|
|
3 |
p. 199-206
|
artikel
|
| 76 |
Hyperglycaemia Induced by Novel Anticancer Agents: An Undesirable Complication or a Potential Therapeutic Opportunity?
|
Shah, Rashmi R.
|
|
2016
|
|
3 |
p. 211-228
|
artikel
|
| 77 |
Impact of Electrocardiographic Data Quality on Moxifloxacin Response in Thorough QT/QTc Studies
|
Johannesen, Lars
|
|
2014
|
|
3 |
p. 183-189
|
artikel
|
| 78 |
Impact of Preventive Strategies on Gastrointestinal Complications in Elderly Patients on Concomitant Use of Oral Anticoagulants and Nonsteroidal Anti-Inflammatory Drugs: A Nationwide Cohort Study
|
Lee, Suhyun
|
|
|
|
3 |
p. 297-304
|
artikel
|
| 79 |
Implications of Individual QT/RR Profiles—Part 1: Inaccuracies and Problems of Population-Specific QT/Heart Rate Corrections
|
Malik, Marek
|
|
2018
|
|
3 |
p. 401-414
|
artikel
|
| 80 |
Implications of Individual QT/RR Profiles—Part 2: Zero QTc/RR Correlations Do Not Prove QTc Correction Accuracy in Studies of QTc Changes
|
Malik, Marek
|
|
2019
|
|
3 |
p. 415-426
|
artikel
|
| 81 |
Improving Data Collection in Pregnancy Safety Studies: Towards Standardisation of Data Elements in Pregnancy Reports from Public and Private Partners, A Contribution from the ConcePTION Project
|
Favre, Guillaume
|
|
|
|
3 |
p. 227-236
|
artikel
|
| 82 |
Improving the Safety of Medicines via Digital Technology: An Assessment of the Scope and Quality of Risk Minimization Websites in the United States and United Kingdom
|
Smith, Meredith Y.
|
|
|
|
3 |
p. 259-274
|
artikel
|
| 83 |
Incidence Rates of Autoimmune Diseases in European Healthcare Databases: A Contribution of the ADVANCE Project
|
Willame, Corinne
|
|
|
|
3 |
p. 383-395
|
artikel
|
| 84 |
Insight into the Severity of Adverse Drug Reactions as Experienced by Patients
|
Rolfes, Leàn
|
|
|
|
3 |
p. 291-293
|
artikel
|
| 85 |
Intensive Monitoring of Pregabalin
|
Härmark, Linda
|
|
2011
|
|
3 |
p. 221-231
|
artikel
|
| 86 |
Intentional Rechallenge and the Clinical Management of Drug-Related Problems
|
Meyboom, Ronald
|
|
2013
|
|
3 |
p. 163-165
|
artikel
|
| 87 |
Intentional Rechallenge: Does the Benefit Outweigh the Risk?
|
Stanulović, Vid
|
|
2013
|
|
3 |
p. 155-161
|
artikel
|
| 88 |
International Trends in Adverse Drug Event-Related Mortality from 2001 to 2019: An Analysis of the World Health Organization Mortality Database from 54 Countries
|
Koyama, Toshihiro
|
|
|
|
3 |
p. 237-249
|
artikel
|
| 89 |
Melanoma and Non-Melanoma Skin Cancer Associated with Angiotensin-Converting-Enzyme Inhibitors, Angiotensin-Receptor Blockers and Thiazides: A Matched Cohort Study
|
Nardone, Beatrice
|
|
2016
|
|
3 |
p. 249-255
|
artikel
|
| 90 |
Near-Real-Time Monitoring of New Drugs: An Application Comparing Prasugrel Versus Clopidogrel
|
Gagne, Joshua J.
|
|
2014
|
|
3 |
p. 151-161
|
artikel
|
| 91 |
Neurodevelopmental Effects of Fetal Antiepileptic Drug Exposure
|
Velez-Ruiz, Naymee J.
|
|
2015
|
|
3 |
p. 271-278
|
artikel
|
| 92 |
Neuropsychiatric Events Associated with Leukotriene-Modifying Agents: A Systematic Review
|
Law, Sharon W. Y.
|
|
2017
|
|
3 |
p. 253-265
|
artikel
|
| 93 |
New Insights in Toxic Epidermal Necrolysis (Lyell’s Syndrome)
|
Paquet, Philippe
|
|
2010
|
|
3 |
p. 189-212
|
artikel
|
| 94 |
Optimizing Safety Surveillance for COVID-19 Vaccines at the Swedish Medical Products Agency
|
Kälkner, Karl Mikael
|
|
|
|
3 |
p. 319-321
|
artikel
|
| 95 |
Oral Contraceptives and Venous Thromboembolism
|
Manzoli, Lamberto
|
|
2012
|
|
3 |
p. 191-205
|
artikel
|
| 96 |
Paradoxical and Bidirectional Drug Effects
|
Smith, Silas W.
|
|
2012
|
|
3 |
p. 173-189
|
artikel
|
| 97 |
Parental Reporting of Adverse Drug Reactions Associated with Attention-Deficit Hyperactivity Disorder (ADHD) Medications in Children Attending Specialist Paediatric Clinics in the UK
|
Tobaiqy, Mansour
|
|
2011
|
|
3 |
p. 211-219
|
artikel
|
| 98 |
PCSK9 Inhibitors and Neurocognitive Adverse Drug Reactions: Analysis of Individual Case Safety Reports from the Eudravigilance Database
|
di Mauro, Gabriella
|
|
|
|
3 |
p. 337-349
|
artikel
|
| 99 |
Pharmacoepidemiologic Evaluation of Birth Defects from Health-Related Postings in Social Media During Pregnancy
|
Golder, Su
|
|
2018
|
|
3 |
p. 389-400
|
artikel
|
| 100 |
Pharmacological Importance of Stereochemical Resolution of Enantiomeric Drugs
|
Islam, Mohamed R.
|
|
|
|
3 |
p. 149-165
|
artikel
|
| 101 |
Pharmacovigilance in India: Present Scenario and Future Challenges
|
Kalaiselvan, V.
|
|
2018
|
|
3 |
p. 339-346
|
artikel
|
| 102 |
Post-Marketing Benefit–Risk Assessment of Rotavirus Vaccination in Japan: A Simulation and Modelling Analysis
|
Ledent, Edouard
|
|
2016
|
|
3 |
p. 219-230
|
artikel
|
| 103 |
Postmarketing Safety Surveillance
|
Coloma, Preciosa M.
|
|
2013
|
|
3 |
p. 183-197
|
artikel
|
| 104 |
Potential Direct Costs of Adverse Drug Events and Possible Cost Savings Achievable by their Prevention in Tuscany, Italy: A Model-Based Analysis
|
Convertino, Irma
|
|
2018
|
|
3 |
p. 427-444
|
artikel
|
| 105 |
Prenatal Exposure to Macrolides and Risk of Congenital Malformations: A Meta-Analysis
|
Mallah, Narmeen
|
|
|
|
3 |
p. 211-221
|
artikel
|
| 106 |
Preventing Future Deaths from Medicines: Responses to Coroners’ Concerns in England and Wales
|
Ferner, Robin E.
|
|
2018
|
|
3 |
p. 445-451
|
artikel
|
| 107 |
Proactive Regional Pharmacovigilance System Versus National Spontaneous Reporting for Collecting Safety Data on Concerning Off-Label Prescribing Practices: An Example with Baclofen and Alcohol Dependence in France
|
Auffret, Marine
|
|
2016
|
|
3 |
p. 257-262
|
artikel
|
| 108 |
Promoting Collaboration of Regulators and Patients in Improving Drug Safety and Regulatory Decision Making
|
Khoo, Yoong Khean
|
|
|
|
3 |
p. 217-225
|
artikel
|
| 109 |
Prospective Drug Safety Monitoring Using the UK Primary-Care General Practice Research Database
|
Johansson, Saga
|
|
2010
|
|
3 |
p. 223-232
|
artikel
|
| 110 |
Renal and Bone Adverse Effects of a Tenofovir-Based Regimen in the Treatment of HIV-Infected Children: A Systematic Review
|
Okonkwo, Rose I.
|
|
2015
|
|
3 |
p. 209-218
|
artikel
|
| 111 |
Reported Adverse Events with Painkillers: Data Mining of the US Food and Drug Administration Adverse Events Reporting System
|
Min, Jae
|
|
2017
|
|
3 |
p. 313-320
|
artikel
|
| 112 |
Reporting Patterns Indicative of Adverse Drug Interactions
|
Strandell, Johanna
|
|
2011
|
|
3 |
p. 253-266
|
artikel
|
| 113 |
Risk Factors and Drug Interactions Predisposing to Statin-Induced Myopathy
|
Chatzizisis, Yiannis S.
|
|
2010
|
|
3 |
p. 171-187
|
artikel
|
| 114 |
Risk of Cancer in Association with Ranitidine and Nizatidine vs Other H2 Blockers: Analysis of the Japan Medical Data Center Claims Database 2005–2018
|
Iwagami, Masao
|
|
|
|
3 |
p. 361-371
|
artikel
|
| 115 |
Risk of Inflammatory Bowel Disease with Oral Contraceptives and Menopausal Hormone Therapy: Current Evidence and Future Directions
|
Khalili, Hamed
|
|
2015
|
|
3 |
p. 193-197
|
artikel
|
| 116 |
Risk of Major Bleeding Associated with Concomitant Direct-Acting Oral Anticoagulant and Clopidogrel Use: A Retrospective Cohort Study
|
Hwang, Y. Joseph
|
|
|
|
3 |
p. 251-260
|
artikel
|
| 117 |
Risk of Psoriasis Following Terbinafine or Itraconazole Treatment for Onychomycosis: A Population-Based Case-Control Comparative Study
|
Chiu, Hsien-Yi
|
|
2017
|
|
3 |
p. 285-295
|
artikel
|
| 118 |
Safety and Tolerability Profile of Second-Line Anti-Tuberculosis Medications
|
Ramachandran, Geetha
|
|
2015
|
|
3 |
p. 253-269
|
artikel
|
| 119 |
Safety of Follitropin Alfa/Lutropin Alfa for Stimulation of Follicular Development
|
Abramova, Nadezda
|
|
2018
|
|
3 |
p. 453-461
|
artikel
|
| 120 |
Safety of N-Acetylcysteine at High Doses in Chronic Respiratory Diseases: A Review
|
Calverley, Peter
|
|
|
|
3 |
p. 273-290
|
artikel
|
| 121 |
Safety of Nortriptyline at Equivalent Therapeutic Doses for Smoking Cessation
|
Dhippayom, Teerapon
|
|
2011
|
|
3 |
p. 199-210
|
artikel
|
| 122 |
Sales of Over-the-Counter Products Containing Codeine in 31 Countries, 2013–2019: A Retrospective Observational Study
|
Richards, Georgia C.
|
|
|
|
3 |
p. 237-247
|
artikel
|
| 123 |
Saquinavir Soft Gelatin Capsule
|
Gill, John
|
|
|
|
3 |
p. 223-232
|
artikel
|
| 124 |
Severe Physical Complications among Survivors of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis
|
Olteanu, Cristina
|
|
2017
|
|
3 |
p. 277-284
|
artikel
|
| 125 |
Signalling Paediatric Side Effects using an Ensemble of Simple Study Designs
|
Reps, Jenna M.
|
|
2014
|
|
3 |
p. 163-170
|
artikel
|
| 126 |
Social Media Mining for Toxicovigilance: Automatic Monitoring of Prescription Medication Abuse from Twitter
|
Sarker, Abeed
|
|
2015
|
|
3 |
p. 231-240
|
artikel
|
| 127 |
Spontaneous Fluctuations in Liver Biochemistries in Patients with Compensated NASH Cirrhosis: Implications for Drug Hepatotoxicity Monitoring
|
Shamseddeen, Hani
|
|
|
|
3 |
p. 281-290
|
artikel
|
| 128 |
Strengthening and Rationalizing Pharmacovigilance in the EU: Where is Europe Heading to?
|
Borg, John-Joseph
|
|
2011
|
|
3 |
p. 187-197
|
artikel
|
| 129 |
Targeting Outpatient Drug Safety
|
Herwaarden, Margaretha F. Warlé-van
|
|
2012
|
|
3 |
p. 245-259
|
artikel
|
| 130 |
The COVID-19 International Drug Pregnancy Registry (COVID-PR): Protocol Considerations
|
Wyszynski, Diego F.
|
|
|
|
3 |
p. 195-204
|
artikel
|
| 131 |
The COVID-19 Vaccines International Pregnancy Exposure Registry (C-VIPER): Protocol and Methodological Considerations
|
Wyszynski, Diego F.
|
|
|
|
3 |
p. 297-308
|
artikel
|
| 132 |
The Extent of Medication-Related Hospital Admissions in Australia: A Review from 1988 to 2021
|
Lim, Renly
|
|
|
|
3 |
p. 249-257
|
artikel
|
| 133 |
The Impact of Provider Networks on the Co-Prescriptions of Interacting Drugs: A Claims-Based Analysis
|
Ong, Mei-Sing
|
|
2016
|
|
3 |
p. 263-272
|
artikel
|
| 134 |
The Moroccan Experience of Implementing a University Curriculum for the Pharmacovigilance of Herbal Medicines (Phytovigilance)
|
Skalli, Souad
|
|
|
|
3 |
p. 285-286
|
artikel
|
| 135 |
The Relationship Between Study Characteristics and the Prevalence of Medication-Related Hospitalizations
|
Leendertse, Anne J.
|
|
2010
|
|
3 |
p. 233-244
|
artikel
|
| 136 |
The Role of European Healthcare Databases for Post-Marketing Drug Effectiveness, Safety and Value Evaluation: Where Does Italy Stand?
|
Trifirò, Gianluca
|
|
2018
|
|
3 |
p. 347-363
|
artikel
|
| 137 |
The Role of European Healthcare Databases for Post-Marketing Drug Effectiveness, Safety and Value Evaluation: Where Does Italy Stand?
|
Trifirò, Gianluca
|
|
|
|
3 |
p. 347-363
|
artikel
|
| 138 |
The Safety of an Adenosine A1-Receptor Antagonist, Rolofylline, in Patients with Acute Heart Failure and Renal Impairment
|
Teerlink, John R.
|
|
2012
|
|
3 |
p. 233-244
|
artikel
|
| 139 |
The 9th International Congress on Cutaneous Adverse Drug Reactions at the 23rd World Congress of Dermatology in Vancouver, 2015
|
Dodiuk-Gad, Roni P.
|
|
2016
|
|
3 |
p. 271-276
|
artikel
|
| 140 |
The UK BIO-TRAC Study: A Cross-Sectional Study of Product and Batch Traceability for Biologics in Clinical Practice and Electronic Adverse Drug Reaction Reporting in the UK
|
Klein, Kevin
|
|
|
|
3 |
p. 255-263
|
artikel
|
| 141 |
Tolerability of Atypical Antipsychotics
|
Stanniland, Claire
|
|
2000
|
|
3 |
p. 195-214
|
artikel
|
| 142 |
Tolerability of Paracetamol
|
Graham, Garry G.
|
|
|
|
3 |
p. 227-240
|
artikel
|
| 143 |
Trimethoprim-Induced Hyperkalaemia
|
Perazella, Mark A.
|
|
2000
|
|
3 |
p. 227-236
|
artikel
|
| 144 |
Use of Prescription Drug Samples in the USA: A Descriptive Study with Considerations for Pharmacoepidemiology
|
Hampp, Christian
|
|
2016
|
|
3 |
p. 261-270
|
artikel
|
| 145 |
Use of Structured Electronic Health Records Data Elements for the Development of Computable Phenotypes to Identify Potential Adverse Events Associated with Intravenous Immunoglobulin Infusion
|
Hurst, Jillian H.
|
|
|
|
3 |
p. 309-318
|
artikel
|
| 146 |
Using Human ‘Experiments of Nature’ to Predict Drug Safety Issues: An Example with PCSK9 Inhibitors
|
Jerome, Rebecca N.
|
|
2017
|
|
3 |
p. 303-311
|
artikel
|
| 147 |
Utilisation and Safety of Deferasirox: Results from an Observational Cohort Study in England
|
Osborne, Vicki
|
|
2017
|
|
3 |
p. 267-275
|
artikel
|
| 148 |
Validating Intelligent Automation Systems in Pharmacovigilance: Insights from Good Manufacturing Practices
|
Huysentruyt, Kristof
|
|
|
|
3 |
p. 261-272
|
artikel
|
| 149 |
Validation of a Novel Method to Assess the Clinical Quality of Information in Pregnancy-Related Pharmacovigilance Case Reports: A ConcePTION Project
|
van Rijt-Weetink, Yrea R. J.
|
|
|
|
3 |
p. 261-270
|
artikel
|
| 150 |
What Factors Make EU Regulators Want to Communicate Drug Safety Issues Related to SGLT2 Inhibitors? An Online Survey Study
|
Roldan Munoz, Sonia
|
|
|
|
3 |
p. 243-255
|
artikel
|
Tijdschrift beschrijving